Stem Cell Evidence's Avatar

Stem Cell Evidence

@stemcellevidence.bsky.social

Curating the evidence in haematopoietic stem cell transplantation. Free monthly Stem Cell Evidence Alert http://bit.ly/2HMQtb5 @stemcellevidence@fediscience.org #MedSky

122 Followers  |  490 Following  |  97 Posts  |  Joined: 20.11.2024  |  1.7825

Latest posts by stemcellevidence.bsky.social on Bluesky

Image showing a PICO summary for:

Daratumumab for PRCA after HCT: study and practical considerations from the EBMT Transplant Complications Working Party
by Gagelmann et al.
featured in the Stem Cell Evidence Alert - July 2025

Image showing a PICO summary for: Daratumumab for PRCA after HCT: study and practical considerations from the EBMT Transplant Complications Working Party by Gagelmann et al. featured in the Stem Cell Evidence Alert - July 2025

From the #StemCellEvidence Alert:

Daratumumab for PRCA after HCT: study and practical considerations from the EBMT Transplant Complications Working Party
by Gagelmann et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

12.08.2025 09:55 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Image showing an extract of the Stem Cell Evidence Alert

Image showing an extract of the Stem Cell Evidence Alert

The latest #StemCellEvidence monthly alert is out!

See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky

11.08.2025 06:13 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

Phase 1/2 Study of High-Dose Palifermin for GVHD Prophylaxis in Patients Undergoing HLA-Matched Unrelated Donor HCT
by Schulz et al.

featured in the Stem Cell Evidence Alert - June 2025

Image showing a PICO summary for: Phase 1/2 Study of High-Dose Palifermin for GVHD Prophylaxis in Patients Undergoing HLA-Matched Unrelated Donor HCT by Schulz et al. featured in the Stem Cell Evidence Alert - June 2025

From the #StemCellEvidence Alert:

Phase 1/2 Study of High-Dose Palifermin for GVHD Prophylaxis in Patients Undergoing HLA-Matched Unrelated Donor HCT
by Schulz et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

14.07.2025 14:52 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A report from the CIBMTR
by Spellman et al.

featured in the Stem Cell Evidence Alert - June 2025

Image showing a PICO summary for: Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A report from the CIBMTR by Spellman et al. featured in the Stem Cell Evidence Alert - June 2025

New from #StemCellEvidence:

Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A report from the CIBMTR
by Spellman et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

11.07.2025 08:24 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

New from #StemCellEvidence:

Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A report from the CIBMTR
by Spellman et al.
www.stemcellevidence.com/alerts/artic...

11.07.2025 08:23 β€” πŸ‘ 4    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

Effect of genetic mutations on outcomes of stem cell transplantation in children with hemophagocytic lymphohistiocytosis
by Γ–ztΓΌrk et al.
featured in the Stem Cell Evidence Alert - June 2025

Image showing a PICO summary for: Effect of genetic mutations on outcomes of stem cell transplantation in children with hemophagocytic lymphohistiocytosis by Γ–ztΓΌrk et al. featured in the Stem Cell Evidence Alert - June 2025

From the #StemCellEvidence Alert:

Effect of genetic mutations on outcomes of stem cell transplantation in children with hemophagocytic lymphohistiocytosis
by Γ–ztΓΌrk et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

10.07.2025 12:56 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

Feasibility and efficacy of partial replacement of post transplantation cyclophosphamide with bendamustine on day +4 for graft versus host disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation
by Nair et al.
featured in the Stem Cell Evidence Alert - June 2025

Image showing a PICO summary for: Feasibility and efficacy of partial replacement of post transplantation cyclophosphamide with bendamustine on day +4 for graft versus host disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation by Nair et al. featured in the Stem Cell Evidence Alert - June 2025

New from #StemCellEvidence:

Feasibility and efficacy of partial replacement of post transplantation cyclophosphamide with bendamustine on day +4 for graft versus host disease prophylaxis (...)
by Nair et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

09.07.2025 09:21 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

Role of Donor Cytomegalovirus Serostatus in Cytomegalovirus-Seronegative Recipients of Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis
by Mehta et al.
featured in the Stem Cell Evidence Alert - June 2025

Image showing a PICO summary for: Role of Donor Cytomegalovirus Serostatus in Cytomegalovirus-Seronegative Recipients of Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis by Mehta et al. featured in the Stem Cell Evidence Alert - June 2025

From the #StemCellEvidence Alert:

Role of Donor Cytomegalovirus Serostatus in Cytomegalovirus-Seronegative Recipients of Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis
by Mehta et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

08.07.2025 12:50 β€” πŸ‘ 1    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT
by Kawamura et al.
featured in the Stem Cell Evidence Alert - June 2025

Image showing a PICO summary for: Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT by Kawamura et al. featured in the Stem Cell Evidence Alert - June 2025

New from #StemCellEvidence:

Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT
by Kawamura et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

07.07.2025 10:07 β€” πŸ‘ 2    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the SociΓ©tΓ© Francophone de Greffe de Moelle et ThΓ©rapie Cellulaire (SFGM-TC)
by Chalandon et al.
featured in the Stem Cell Evidence Alert - June 2025

Image showing a PICO summary for: Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the SociΓ©tΓ© Francophone de Greffe de Moelle et ThΓ©rapie Cellulaire (SFGM-TC) by Chalandon et al. featured in the Stem Cell Evidence Alert - June 2025

From the #StemCellEvidence Alert:

Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study (...)
by Chalandon et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

04.07.2025 09:16 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

Comparison of Chimerism Kinetics and Associated Outcomes in Patients Receiving Post-Transplant Cyclophosphamide Versus Methotrexate based GVHD Prophylaxis Following Allogeneic Hematopoietic Cell Transplant
by Baranwal et al.
featured in the Stem Cell Evidence Alert - June 2025

Image showing a PICO summary for: Comparison of Chimerism Kinetics and Associated Outcomes in Patients Receiving Post-Transplant Cyclophosphamide Versus Methotrexate based GVHD Prophylaxis Following Allogeneic Hematopoietic Cell Transplant by Baranwal et al. featured in the Stem Cell Evidence Alert - June 2025

New from #StemCellEvidence

Comparison of Chimerism Kinetics and Associated Outcomes in Patients Receiving Post-Transplant Cyclophosphamide Versus Methotrexate based GVHD Prophylaxis Following Allogeneic Hematopoietic Cell Transplant
by Baranwal et al
www.stemcellevidence.com/alerts/artic...
#MedSky

03.07.2025 11:50 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

Outcomes of Allogeneic Hematopoietic Stem Cell Transplant in Monogenic Inflammatory Bowel Disease
by Baccarella et al.
featured in the Stem Cell Evidence Alert - June 2025

Image showing a PICO summary for: Outcomes of Allogeneic Hematopoietic Stem Cell Transplant in Monogenic Inflammatory Bowel Disease by Baccarella et al. featured in the Stem Cell Evidence Alert - June 2025

From the #StemCellEvidence Alert:

Outcomes of Allogeneic Hematopoietic Stem Cell Transplant in Monogenic Inflammatory Bowel Disease
by Baccarella et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

02.07.2025 09:03 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

Darbepoetin, Red Cell Mass, and Neuroprotection in Preterm Infants: A Randomized Clinical Trial
by Ohls et al.
featured in the Transfusion Evidence Alert - June 2025

Image showing a PICO summary for: Darbepoetin, Red Cell Mass, and Neuroprotection in Preterm Infants: A Randomized Clinical Trial by Ohls et al. featured in the Transfusion Evidence Alert - June 2025

New from the #Transfusion Evidence Alert:

Darbepoetin, Red Cell Mass, and Neuroprotection in Preterm Infants: A Randomized Clinical Trial
by Ohls et al.
www.transfusionevidencelibrary.com/articles/403...
#MedSky

02.07.2025 08:50 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHD
by Habenicht et al.
featured in the Stem Cell Evidence Alert - June 2025

Image showing a PICO summary for: Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHD by Habenicht et al. featured in the Stem Cell Evidence Alert - June 2025

From the #StemCellEvidence Alert:

Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHD
by Habenicht et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

01.07.2025 09:22 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

Liberal transfusion strategies reduce sepsis risk and improve neurological recovery in acute brain injury: an updated #systematicreview and #metaanalysis
by Nguyen et al.
featured in the Transfusion Evidence Alert - June 2025

Image showing a PICO summary for: Liberal transfusion strategies reduce sepsis risk and improve neurological recovery in acute brain injury: an updated #systematicreview and #metaanalysis by Nguyen et al. featured in the Transfusion Evidence Alert - June 2025

New from the #Transfusion Evidence Alert:

Liberal transfusion strategies reduce sepsis risk and improve neurological recovery in acute brain injury: an updated #systematicreview and #metaanalysis
by Nguyen et al.
www.transfusionevidencelibrary.com/articles/403...
#MedSky

30.06.2025 10:20 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

Real-world outcomes of brentuximab vedotin as consolidation therapy after autologous stem cell transplantation in relapsed/refractory Hodgkin lymphoma: A #systematicreview and #metaanalysis
by Sureda et al.
featured in the Stem Cell Evidence Alert - May 2025

Image showing a PICO summary for: Real-world outcomes of brentuximab vedotin as consolidation therapy after autologous stem cell transplantation in relapsed/refractory Hodgkin lymphoma: A #systematicreview and #metaanalysis by Sureda et al. featured in the Stem Cell Evidence Alert - May 2025

New from the #StemCellEvidence Alert:

Real-world outcomes of brentuximab vedotin as consolidation therapy after autologous stem cell transplantation in relapsed/refractory Hodgkin lymphoma: A #systematicreview and #metaanalysis
by Sureda et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

16.06.2025 12:23 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party
by Penack et al.
featured in the Stem Cell Evidence Alert - May 2025

Image showing a PICO summary for: GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party by Penack et al. featured in the Stem Cell Evidence Alert - May 2025

From the #StemCellEvidence Alert:

GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party
by Penack et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

13.06.2025 12:02 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

Influence of pre-transplant estimated glomerular filtration rate (eGFR) on clinical outcomes after allogeneic hematopoietic cell transplantation
by Nurse et al.
featured in the Stem Cell Evidence Alert - May 2025

Image showing a PICO summary for: Influence of pre-transplant estimated glomerular filtration rate (eGFR) on clinical outcomes after allogeneic hematopoietic cell transplantation by Nurse et al. featured in the Stem Cell Evidence Alert - May 2025

New from the #StemCellEvidence Alert:

Influence of pre-transplant estimated glomerular filtration rate (eGFR) on clinical outcomes after allogeneic hematopoietic cell transplantation
by Nurse et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

12.06.2025 11:58 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

How low can we go? Comparison of liberal and restrictive red cell transfusion thresholds in paediatric allogeneic haematopoietic stem cell transplantation: A randomized multicentre feasibility trial
by New et al.
featured in the Transfusion Evidence Alert - May 2025

Image showing a PICO summary for: How low can we go? Comparison of liberal and restrictive red cell transfusion thresholds in paediatric allogeneic haematopoietic stem cell transplantation: A randomized multicentre feasibility trial by New et al. featured in the Transfusion Evidence Alert - May 2025

New from the #Transfusion Evidence Alert:

How low can we go? Comparison of liberal and restrictive red cell transfusion thresholds in paediatric allogeneic haematopoietic stem cell transplantation (...)
by New et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky

12.06.2025 11:41 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

The Impact of Melphalan Conditioning and CD34+ Cell Dose and Schedule on Post-Transplant Outcomes in AL Amyloidosis
by Muchtar et al.
featured in the Stem Cell Evidence Alert - May 2025

Image showing a PICO summary for: The Impact of Melphalan Conditioning and CD34+ Cell Dose and Schedule on Post-Transplant Outcomes in AL Amyloidosis by Muchtar et al. featured in the Stem Cell Evidence Alert - May 2025

From the #StemCellEvidence Alert:

The Impact of Melphalan Conditioning and CD34+ Cell Dose and Schedule on Post-Transplant Outcomes in AL Amyloidosis
by Muchtar et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

11.06.2025 09:00 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis of the French cohort of the compassionate use program, on behalf of the French Society of Bone Marrow Transplantation and Cellular Therapy
by Michonneau et al.

featured in the Stem Cell Evidence Alert - May 2025

Image showing a PICO summary for: Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis of the French cohort of the compassionate use program, on behalf of the French Society of Bone Marrow Transplantation and Cellular Therapy by Michonneau et al. featured in the Stem Cell Evidence Alert - May 2025

New from the #StemCellEvidence Alert:

Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis (...)
by Michonneau et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

10.06.2025 12:35 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV. A retrospective analysis of the EBMT Lymphoma Working Party in collaboration with GELTAMO, FIL, LYSA, and Turkish Lymphoma Group
by MartΓ­nez et al.
featured in the Stem Cell Evidence Alert - May 2025

Image showing a PICO summary for: Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV. A retrospective analysis of the EBMT Lymphoma Working Party in collaboration with GELTAMO, FIL, LYSA, and Turkish Lymphoma Group by MartΓ­nez et al. featured in the Stem Cell Evidence Alert - May 2025

From the #StemCellEvidence Alert:

Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV (...)
by MartΓ­nez et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

09.06.2025 07:47 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

Examining the role of voluntary reciprocal altruism and collectivism interventions in enhancing intentions to donate blood among young non-donors: an experimental study
by Duffy and Molloy
featured in the Transfusion Evidence Alert - May 2025

Image showing a PICO summary for: Examining the role of voluntary reciprocal altruism and collectivism interventions in enhancing intentions to donate blood among young non-donors: an experimental study by Duffy and Molloy featured in the Transfusion Evidence Alert - May 2025

From the #Transfusion Evidence Alert:

Examining the role of voluntary reciprocal altruism and collectivism interventions in enhancing intentions to donate blood among young non-donors: an experimental study
by Duffy and Molloy
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky

09.06.2025 07:39 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

GvHD prophylaxis with tacrolimus, sirolimus, and mycophenolate mofetil after reduced intensity conditioning hematopoietic stem cell allogeneic transplantation
by Lopez-Corral et al.
featured in the Stem Cell Evidence Alert - May 2025

Image showing a PICO summary for: GvHD prophylaxis with tacrolimus, sirolimus, and mycophenolate mofetil after reduced intensity conditioning hematopoietic stem cell allogeneic transplantation by Lopez-Corral et al. featured in the Stem Cell Evidence Alert - May 2025

New from the #StemCellEvidence Alert:

GvHD prophylaxis with tacrolimus, sirolimus, and mycophenolate mofetil after reduced intensity conditioning hematopoietic stem cell allogeneic transplantation
by Lopez-Corral et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

06.06.2025 08:17 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for: 

Omidubicel-onlv Transplantation for Hematologic Malignancies: Results of a Multicenter Expanded Access Program
by Horwitz et al.
featured in the Stem Cell Evidence Alert - May 2025

Image showing a PICO summary for: Omidubicel-onlv Transplantation for Hematologic Malignancies: Results of a Multicenter Expanded Access Program by Horwitz et al. featured in the Stem Cell Evidence Alert - May 2025

From the #StemCellEvidence Alert:

Omidubicel-onlv Transplantation for Hematologic Malignancies: Results of a Multicenter Expanded Access Program
by Horwitz et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

05.06.2025 05:48 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

#Systematicreview and #metaanalysis of intravenous iron therapy for patients with heart failure and iron deficiency
by Anker et al.
featured in the Transfusion Evidence Alert - May 2025

Image showing a PICO summary for: #Systematicreview and #metaanalysis of intravenous iron therapy for patients with heart failure and iron deficiency by Anker et al. featured in the Transfusion Evidence Alert - May 2025

From the #Transfusion Evidence Alert:

#Systematicreview and #metaanalysis of intravenous iron therapy for patients with heart failure and iron deficiency
by Anker et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky

05.06.2025 05:41 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial
by Anker et al.

featured in the Transfusion Evidence Alert - May 2025

Image showing a PICO summary for: Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial by Anker et al. featured in the Transfusion Evidence Alert - May 2025

New from the #Transfusion Evidence Alert:

Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial
by Anker et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky

04.06.2025 07:25 β€” πŸ‘ 1    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation
by Aubrey et al.

featured in the Stem Cell Evidence Alert - May 2025

Image showing a PICO summary for: A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation by Aubrey et al. featured in the Stem Cell Evidence Alert - May 2025

New from the #StemCellEvidence Alert:

A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation
by Aubrey et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

04.06.2025 07:34 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis
by Hernandez-Boluda et al.

featured in the Stem Cell Evidence Alert - May 2025

Image showing a PICO summary for: Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis by Hernandez-Boluda et al. featured in the Stem Cell Evidence Alert - May 2025

From the #StemCellEvidence Alert:

Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis
by Hernandez-Boluda et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

03.06.2025 06:02 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Image showing a PICO summary for:

The cost-effectiveness of interventions used for the screening, diagnosis and management of anaemia in pregnancy: A #systematicreview
by Allen et al.

featured in the Transfusion Evidence Alert - May 2025

Image showing a PICO summary for: The cost-effectiveness of interventions used for the screening, diagnosis and management of anaemia in pregnancy: A #systematicreview by Allen et al. featured in the Transfusion Evidence Alert - May 2025

From the #Transfusion Evidence Alert:

The cost-effectiveness of interventions used for the screening, diagnosis and management of anaemia in pregnancy: A #systematicreview
by Allen et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky

03.06.2025 05:49 β€” πŸ‘ 2    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0

@stemcellevidence is following 20 prominent accounts